The WHO Prequalification Team announces that the Emergency Use Listing (EUL) will now be open to candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 (originally called 2019-nCoV). An invitation to manufacturers of IVDs to detect SARS-CoV-2 to submit an Expression of Interest (EOI) for assessment of candidate IVDs under the EUL procedure was issued on 28 February 2020: